Metrics as of 10/14/2026, 12:15 PM (Berlin time), refresh in progress.
Eloxx Pharmaceuticals Stock
Eloxx Pharmaceuticals, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Sumit Aggarwal
- Employees
- 10
- Market cap
- $44 M
- IPO
- 09/06/2026
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical firm that specializes in developing therapeutic solutions through ribosome modulation. Its primary objective is to address rare and ultra-rare genetic diseases that arise from premature stop codons. The company's most advanced investigational compound,…
Eloxx Pharmaceuticals stock: price history
1D
-8.6%
1W
-16.1%
1M
-19.4%
6M
–
YTD
–
1Y
–
2Y
–
5Y
–
10Y
–
Next earnings date
Next earnings date
11/11/2026 (in 25 days)
Volatility around earnings
~13% weaker price swings than usual
Ask the agents about Eloxx Pharmaceuticals
Analyst assessment of Eloxx Pharmaceuticals
PRICE TARGET LOW
US$32.00
CONSENSUS
US$37.67
MEDIAN
US$38.00
PRICE TARGET HIGH
US$43.00
0
STRONG BUY
9
BUY
3
HOLD
0
SELL
0
STRONG SELL
12
TOTAL · Buy
As of: 24/08/2026
Eloxx Pharmaceuticals stock metrics
P/E
-8.36
P/B
1.86
EV/EBITDA
2.24
RETURN ON EQUITY
-9.7%
NET MARGIN
0.0%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
9.0%
FLOAT SHARES
310,607
AVG. DAILY VOLUME (30D)
26,933
Insider transactions (SEC)
Domicilium Real Estate Fund III LP
Domicilium Real Estate Fund III LP
Domicilium Real Estate Fund III LP
Coastlands Capital LP
Walts Alan Edmund
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Eloxx Pharmaceuticals stock
What does Eloxx Pharmaceuticals do?
Eloxx Pharmaceuticals, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Sumit Aggarwal, the company employs around 10 people.
The IPO was on 09/06/2026; the stock trades on NASDAQ under the ticker ELOX.
What do analysts say about Eloxx Pharmaceuticals stock?
12 analysts rate the stock, the consensus is Buy (as of 24/08/2026).
The average price target is US$37.67, ranging from US$32.00 to US$43.00, with a median of US$38.00.
This is an external assessment, not a statement by Market Jury.
When does Eloxx Pharmaceuticals report next?
The next earnings date is 11/11/2026.
Around past earnings, price swings were roughly -13% stronger than usual.
Does Eloxx Pharmaceuticals pay a dividend?
No, Eloxx Pharmaceuticals currently does not pay a dividend.
Which stocks are comparable to Eloxx Pharmaceuticals?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get Eloxx Pharmaceuticals stock analyzed?
Clicking "Analyze stock" lets five strategies assess Eloxx Pharmaceuticals against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.